Código QR

Letrozole and palbociclib in advanced breast cancer: Outcome from cancer institute, Chennai

Background: Cyclin-dependent kinase 4/6 inhibitor addition to hormonal therapy has shown to improve the survival of hormone receptor (HR)-positive, HER2-negative advanced breast cancer (ABC). Methods: We retrospectively analyzed untreated patients with HR-positive, HER2-negative ABC, who received le...

ver descrição completa

Na minha lista:
Principais autores: Vijay Gnanaguru, Manikandan Dhanushkodi, Venkatraman Radhakrishnan, Jayachandran Perumal Kalaiarasi, Nikita Mehra, Archit Joshi, Arun Kumar Rajan, Gangothri Selvarajan, Parathan Karunakaran, Balasubramanian Ananthi, Priya Iyer, Geetha Senguttuvan, Manjula Rao, Madhu Priya, Arvind Krishnamurthy, Sridevi Velusamy, Hemanth Raj, Rama Ranganathan, Shirley Sundersingh, Krishna Kumar, Selvaluxmy Ganesarajah, Trivadi S Ganesan, Tenali Gnana Sagar
Formato: Artigo
Idioma:Inglês
Publicado em: Thieme Medical and Scientific Publishers Pvt. Ltd. 2020-01-01
Colecção:Indian Journal of Medical and Paediatric Oncology
Assuntos:
advanced breast cancer
letrozole
palbociclib
Acesso em linha:http://www.ijmpo.org/article.asp?issn=0971-5851;year=2020;volume=41;issue=2;spage=182;epage=186;aulast=
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados